Events & Lectures

The Rockefeller University

Scientists in the Rout and Chait labs, along with colleagues at Seattle Children's, have identified hundreds of llama-derived antibodies that potentially could be developed into a COVID treatment. They hope such a drug would be potent against different variants of the coronavirus, including Omicron. #Rockefellerscience ... See MoreSee Less

The Rockefeller University

Applications are now being accepted for RockEDU Science Outreach's Summer Science Research Program. SSRP provides high school students with a unique opportunity to conduct hands-on research under the mentorship of leading scientists right here at Rockefeller in NYC. Learn more on our website. ... See MoreSee Less

The Rockefeller University

Rockefeller's Paul Bieniasz in NPR: research so far suggests that people can boost their protection—against any variant—by having three exposures to the virus. So that means either three doses of the vaccine or two doses after a natural infection. ... See MoreSee Less

The Rockefeller University

A new study from the Fuchs lab finds that epidermal stem cells that hail from the hair follicle retain memories of their journey to the skin's surface. Those memories are a boon for wound repair, but may also contribute to chronic diseases and cancer. #Rockefellerscience ... See MoreSee Less

The Rockefeller University

Rockefeller's Theodora Hatziioannou on what scientists know about the Omicron variant so far in The New York Times:

Dr. Hatziioannou and her colleagues have been able to produce mutant spike proteins in their laboratory that make viruses highly resistant to Covid-19 antibodies. She said that Omicron has many mutations in the same regions of the spike protein pinpointed in their own research. “The overlap is pretty striking,” she said.

That overlap has Dr. Hatziioannou concerned that Omicron will be able to evade some of the antibodies that people have acquired either from vaccines or from Covid-19 infections. Some monoclonal antibody treatments won’t work against Omicron either, she predicted, because the variant’s spike protein is protected from them.

Still, vaccines are expected to provide some protection against Omicron because they stimulate not only antibodies but immune cells that can attack infected cells, Dr. Hatziioannou said. Mutations to the spike protein do not blunt that immune-cell response. ... See MoreSee Less